# ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease

> **NCT01772693** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 27 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DEVICE:** ExAblate Transcranial MRgFUS
- **DEVICE:** Sham ExAblate Transcranial MRgFUS

## Key facts

- **NCT ID:** NCT01772693
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2016-04-26
- **Final completion:** 2019-03
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772693, "ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01772693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*